Related Experiment Videos
Models for assessing scar tissue inhibitors
Abstract:
The main purpose of animal models for proliferative vitreoretinopathy (PVR) is to develop pharmacologic therapies for this common cause of blindness. A very large number of pharmacologic agents appear to have potential use in this application by preventing cell proliferation and/or contraction. In practice, however, it has been found that prohibitively extensive numbers of animals and laboratory services are required to establish drug efficacy, safety, and dosage regimes. To lessen this work load and to accelerate drug screening programs, the authors have developed an in vitro model for PVR based on chorioretinal fibroblast growth in three-dimensional collagen lattices. This model yields precise data on the effect of drugs on cell proliferation and contractility. Trifluoperazine, colchicine, 5-fluorouracil, dexamethasone, and penicillamine were screened in this model. The first three agents were found to be inhibitory; on the basis of the pharmaco kinetic data, obtained dosage regimes for animal testing were developed. The results obtained are discussed in terms of the in vitro model and the biochemical action of these drugs on the cellular events in PVR. In vitro screening of drugs prior to animal testing offers a significant advance in the quest for a pharmacologic prevention of blindness due to PVR.
Insights
An in vitro model for proliferative vitreoretinopathy (PVR) accelerates drug screening by precisely measuring drug effects on cell proliferation and contraction, reducing animal testing for blindness therapies.
Area of Science:
- Ophthalmology
- Pharmacology
- Cell Biology
Background:
- Proliferative vitreoretinopathy (PVR) is a common cause of blindness.
- Current animal models for PVR drug development are resource-intensive.
- Need for efficient methods to screen pharmacologic agents for PVR.
Purpose of the Study:
- To develop and validate an in vitro model for PVR drug screening.
- To assess the efficacy of specific pharmacologic agents in this model.
- To reduce the workload and accelerate drug discovery for PVR.
Main Methods:
- Developed an in vitro model using chorioretinal fibroblast growth in 3D collagen lattices.
- Screened trifluoperazine, colchicine, 5-fluorouracil, dexamethasone, and penicillamine.
- Measured drug effects on fibroblast proliferation and lattice contraction.
Main Results:
- The in vitro model provided precise data on drug effects.
- Trifluoperazine, colchicine, and 5-fluorouracil demonstrated inhibitory effects.
- Pharmacokinetic data informed dosage regimes for subsequent animal testing.
Conclusions:
- In vitro screening significantly advances the development of pharmacologic therapies for PVR.
- This model reduces the need for extensive animal testing in early drug discovery.
- Accelerated screening facilitates the search for effective treatments to prevent blindness from PVR.